IQVIA Digital Site Suite

  1. One Home For Sites Partnership Program Guide 4/7/2024

    When sponsors of trials adopt IQVIA One Home for Sites, they reduce the burden on their clinical research sites and on their own organizations.

  2. Study Start-Up Challenges: Hard Realities, Effective Strategies 3/13/2024

    Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

  3. Introducing One Home for Sites 2/8/2024

    Join the movement to increase clinical research site capacity. IQVIA One Home for Sites serves as a neutral aggregator, connector, and communicator of the key systems and tasks sites need to perform.

  4. Accelerating Site Activation: Examples From Novartis And IQVIA 1/12/2024

    As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

  5. Q&A With Novartis And IQVIA Study Start-Up Leaders 12/6/2023

    The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines.

  6. Orchestrated Study Start-Up 10/16/2023

    Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.

  7. Practical Approaches To Faster Study Start-Ups 9/25/2023

    Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.

  8. The Impact Of Clinical Trial Payments On Site-Sponsor Relationships 7/18/2023

    The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.

  9. Crowdsource UAT: An Opportunity For Future Validation 6/28/2023

    IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.

  10. Reduce Workloads And Improve Insights With Crowdsource UAT 6/28/2023

    Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.